For Families

Pharming Clinical Trials

[Phase 3] Study of Efficacy of CDZ173 in Patients With APDS/PASLI*


[Phase3] Extension to Study of Efficacy of CDZ173 in Patients with APDS/PASLI*


[Phase 3] Pediatric Patients Aged 4 – 11 Years with APDS*


[Phase 3] Pediatric Patients Aged 1 – 6 Years with APDS

To learn more contact Pharming’s Medical Information
department via the email below.

Stay informed

Sign up for APDS updates

PI is also referred to as an Inborn Error of Immunity (IEI).


1. “What Are Clinical Trials and Studies?” National Institute on Aging, U.S. Department of Health and Human Services, 9 Apr. 2020,

Please note: You are going to a product website.

Please note: You are about to leave the website.